Physical state of human papillomavirus type 16 in cervical cell DNA

Folia Biologica

Volumn 56, Issue 3-4, 2008, Pages 269-271

  Szostek, Sława ^a   Klimek, Małgorzata ^b   Zawilińska, Barbara ^a   Kosz Vnenchak, Magdalena ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

HPV 16; Human papillomavirus genes; Malignancy

Indexed keywords

DNA BINDING PROTEIN; E2 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; PRIMER DNA; REPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; FEMALE; GENETICS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; UTERINE CERVIX; VIROLOGY; VIRUS INFECTION;

ADULT; AGED; CERVIX UTERI; DNA PRIMERS; DNA-BINDING PROTEINS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 48249136951     PISSN: 00155497     EISSN: None     Source Type: Journal    
DOI: 10.3409/fb.56_3-4.269-271     Document Type: Article

References (12)

1. BOSCH F. X., LORINCZ A., MUNOZ N., MEIJER C. J., SHAH K. V. 2002. The causal relation between human papillomavirus and cervical cancer. J.Clin.Pathol. 55: 244-265.
2. HECK D. V., YEE C. L., HOWLEY P. M., MUNGER K. 1992. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomavirus. Proc. Natl. Acad. Sci. USA 89: 4442-4446.
3. HUDELIST G., MANAVI M., PISCHINGER K., WATKINS-RIEDEL T., SINGER C. F., KUBISTA E., CZERWENKA K. F. 2004. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol. Oncol. 92: 873-880.
4. MUNGER K.., PHELPS W. C., BUBB V., HOWLEY P. M., SCHLEGEL R. 1989. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation primary human keratinocytcs. J. Virol. 63: 4417-4421.
5. MUŇOZ N., BOSCH F. X, DE SANJOSE S., HERRERO R., CASTELLSAGUE X., SHAH K. V., SNIJDERS P. J. F., MEIJER C.J. L. M. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348: 518-527.
6. NAGAO S., YOSHINOUCHI M., MIYAGI Y., HONGO A., KODAMA J., ITOH S., KUDO T. 2002. Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative real-time PCR. J. Clin. Microbiol. 40: 863-867.
7. PARK J., HWANG E., PARK S., AHN H., UM S., KIM C., KIM S., NAMKOONG S. 1997. Physical status and expression of HPV genes in cervical cancers. Gynecol. Oncol. 65: 121-129.
8. SCHEFFNER M., WERNESS B. A., HUIBREGTSE J. M., LEVINE A. J., HOWLEY P. M. 1990. The E6 oncoprotein encoded by human papillomavirus type 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136.
9. WOODWORTH C. D., DONIGER J., DIPAOLA J. A. 1989. Immortalization of human keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma. J. Virol. 63: 159-164.
10. YOSHINOUCHI M., HONGO A., NAKAMURA K., KODAMA J., ITOH S., SAKAI H., KUDO T. 1999. Analysis by multiplex PCR of the physical status of human papillomavirus type 16 DNA in cervical cancer. J. Clin. Microbiol. 37: 3514-3517.
11. ZUR HAUSEN H. 2000. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst. 92: 690-698.
12. ZUR HAUSEN H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2: 342-350.